Analysis of a Temperature-Sensitive Vaccinia Virus Mutant in the Viral mRNA Capping Enzyme Isolated by Clustered Charge-to-Alanine Mutagenesis and Transient Dominant Selection  by Hassett, Daniel E et al.
VIROLOGY 238, 391–409 (1997)
ARTICLE NO. VY978820
Analysis of a Temperature-Sensitive Vaccinia Virus Mutant in the Viral mRNA Capping Enzyme
Isolated by Clustered Charge-to-Alanine Mutagenesis and Transient Dominant Selection
Daniel E. Hassett,*,1 Jackie I. Lewis,* Xuekun Xing,† Luke DeLange,† and Richard C. Condit*,2
*Department of Molecular Genetics and Microbiology and Center for Mammalian Genetics, University of Florida, PO Box 100266, Gainesville,
Florida 32610, and †Department of Human Genetics, University of Manitoba, Winnipeg, Manitoba, Canada R3E OW3
Received June 27, 1997; returned to author for revision August 6, 1997; accepted September 2, 1997
We have previously reported the successful development of a targeted genetic method for the creation of temperature-
sensitive vaccinia virus mutants [D. E. Hassett and R. C. Condit (1994) Proc. Natl. Acad. Sci. USA 91, 4554–4558]. This
method has now been applied to the large subunit of the multifunctional vaccinia virus capping enzyme, encoded by gene
D1R. Ten clustered charge-to-alanine mutations were created in a cloned copy of D1R. Four of these mutations were
successfully transferred into the viral genome using transient dominant selection, and each of these four mutations yielded
viruses with plaque phenotypes different from that of wild-type virus. Two of the mutant viruses, 516 and 793, were
temperature sensitive in a plaque assay. Mutant 793 was also temperature sensitive in a one-step growth experiment.
Phenotypic characterization of the 793 virus under both permissive and nonpermissive conditions revealed nearly normal
patterns of viral protein and mRNA synthesis. Under nonpermissive conditions the 793 virus was defective in telomere
resolution and blocked at an intermediate stage of viral morphogenesis. In vitro assays of various capping enzyme activities
revealed that in permeabilized virions, enzyme guanylylate intermediate formation was reduced and methyltransferase
activity was thermolabile, while in solubilized virion extracts enzyme guanylylate activity was reduced and both guanylyltrans-
ferase and methyltransferase activities were absent. Thus, the 793 mutation affects at least two separate enzymatic activities
of the capping enzyme, guanylyltransferase and methyltransferase, and when incorporated into the virus genome, the
mutation yields a virus that is temperature sensitive for growth, telomere resolution, and virion morphogenesis. q 1997
Academic Press
INTRODUCTION cessing of vaccinia mRNA (Moss, 1996). The capping
enzyme is a heterodimer, with subunits of 97 and 33 kDa,
Vaccinia, an orthopoxvirus, is a large (192-kb) double-
encoded by the D1R and D12L genes, respectively (Guo
stranded DNA virus that replicates in the cytoplasm of
and Moss, 1990; Niles et al., 1986, 1989; Shuman, 1990;
infected cells (Moss, 1996). One consequence of cyto-
Morgan et al., 1984). Biochemical experiments demon-
plasmic replication is that the virus must encode most of
strate that the vaccinia capping enzyme is solely respon-
the proteins necessary for DNA replication and regulated
sible for converting the 5* triphosphorylated end of na-
gene expression. Vaccinia gene expression is regulated
scent viral mRNA to a guanylylated, methylated cap 0
primarily at the level of transcription. During infection,
structure (Martin et al., 1975; Ensinger et al., 1975; Tutas
vaccinia genes are transcribed in a cascade comprising
and Paoletti, 1977; Venkatesan et al., 1980) and that it
three temporally distinct phases: early, intermediate, and
also serves as one of several factors required for termi-late. Transcription from each class of genes is modulated
nation of early gene transcription (Shuman et al., 1987)by class-specific cis- and trans-acting factors. Early
and for initiation of intermediate gene transcription (Vosgenes are transcribed by enzymes packaged within the
et al., 1991). In addition, characterization of a tempera-virion, a subset of early proteins then act as transcription
ture-sensitive mutant in the D12L gene implicates thefactors for intermediate genes, a subset of which then
capping enzyme in the resolution of viral DNA concata-serve as transcription factors for late gene expression.
mers late during infection (Carpenter and Delange, 1991;The cascade is completed by the packaging within the
Carpenter et al., 1997). Biochemical experiments havedeveloping virion of the transcriptional machinery
begun to dissect the functional subdomain structure ofneeded for early gene expression.
this enzyme, to determine how a relatively simple struc-The vaccinia virus-coded mRNA capping enzyme plays
ture assists in such a complex array of functions. How-a key multifaceted role in regulated synthesis and pro-
ever, classical genetic methods have as yet yielded no
conditional lethal virus mutants in the D1R subunit the
1 Present address: Department of Neuropharmacology, The Scripps examination of which might aid in understanding the role
Research Institute CVN-9, 10550 North Torrey Pines Road, La Jolla CA
of the capping enzyme in vivo.92037.
Conversion of a nascent 5*-triphosphorylated RNA to2 To whom reprint requests should be addressed. E-mail: condit@
college.med.ufl.edu. a guanylylated, methylated cap 0 structure is catalyzed
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FIG. 1. D1R domain structure and mutants. The amino acid sequence of the D1R protein is shown. Mutants: Ten clustered charge-to-alanine
mutations are indicated by numbers written below the sequence. The numbers refer to the first amino acid changed in each mutant. For each
mutant, the underlined residues were all changed to alanines. Mutant designations that are italicized and underlined indicate mutations that were
recovered in virus. Domains: Regions that when mutated affect only RNA triphosphatase activity are overlined and labeled with a lowercase p. Four
conserved sequences common to guanylyltransferases are overlined and labeled with an uppercase G. The active-site lysine at position 260 is
indicated with an overhead dot. A conserved methyltransferase sequence is overlined and labeled with an uppercase M. A region that when
mutated affects only methyltransferase activity is overlined and labeled with a lowercase m. Residues that when mutated affect heterodimer subunit
interaction are italicized.
by the heterodimeric vaccinia virus mRNA capping en- et al., 1992, 1994; Cong and Shuman, 1992). Specifically,
an isolated amino terminal 60-kDa fragment of D1R, en-zyme in three steps:
compassing amino acids 1–545, is fully active in both the
(1) pppN(pN)n r ppN(pN)n / Pi (RNA triphosphatase), guanylyltransferase and RNA triphosphatase reactions
(2) ppN(pN)n / GTP r GpppN(pN)n / PPi (guanylyl- (Myette and Niles, 1996). D1R mutants have been iso-
transferase),
lated that are defective in either RNA triphosphatase or
(3) GpppN(pN)n / AdoMet r MeGpppN(pN)n / AdoHcy guanylyltransferase activity but not both, suggesting that
((guanine-7-)methyltransferase).
the active sites for these activities are separate and that
the active site for the RNA triphosphatase is N terminalSignificant progress has been made in identifying sub-
domains of the capping enzyme responsible for each of with respect to the guanylyltransferase activity (Yu and
Shuman, 1996; Cong and Shuman, 1995). Both compara-these reactions (Fig. 1). The D1R subunit contains the
active sites for all three activities. The RNA triphospha- tive sequence analysis and genetic analysis identify four
conserved amino acid sequence domains associatedtase and guanylyltransferase reactions can be carried
out by D1R protein in the absence of D12L protein; how- with guanylyltransferase activity, and mutation within
these domains selectively affects guanylyl transferaseever, full methyltransferase activity has been observed
only when the D1R subunit is complexed with the D12L activity (Cong and Shuman, 1995). One of these domains
contains the active-site lysine (Lys-260) which forms asubunit (Shuman and Morham, 1990; Higman et al., 1992;
Mao and Shuman, 1994). The N-terminal two-thirds of covalent enzyme intermediate with GMP during guanylyl
transfer (Cong and Shuman, 1993; Niles and Christen,D1R comprises both the RNA triphosphatase and guan-
ylyltransferase domains (Higman et al., 1992; Shuman and 1993). Limited methyltransferase activity can be ob-
served using the isolated carboxy-terminal 346 aminoMorham, 1990; Niles et al., 1994), whereas the carboxy-
terminal one-third of D1R, complexed with the D12L sub- acids (amino acids 498–844) of D1R, and full methyl-
transferase activity is observed when this fragment isunit, comprises the methyltransferase domain (Higman
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complexed with the D12L subunit of the enzyme (Higman (relative to the transcriptional start site) of the D1R gene.
Following mutagenesis the mutant D1R genes were sub-et al., 1994). The carboxy-terminal D1R subdomain also
contains two S-adenosylmethionine (Adomet) photo- cloned as 2.8-kb PstI–SacI fragments from mutagenized
M13mp18D1RNco- into the vector pBSgptB (a gift fromcrosslinking sites (residues 499–579 and 806–844), and
mutations within this domain have been isolated that Dr. P. Turner, University of Florida) cut with PstI and
SacI (Turner and Moyer, 1995). pBSgptB contains theabrogate both D12L subunit binding and methyltransfer-
ase activity or methyltransferase activity alone (Mao and Escherichia coli guanine phopshoribosyltransferase
gene (ecogpt), a dominant selectable marker, under theShuman, 1994, 1996; Higman and Niles, 1994).
To date attempts to identify subdomains of the capping transcriptional control of a vaccinia P7.5k early/late pro-
moter inserted into pBSKS/ (Stratagene). The resultingenzyme responsible for early gene transcription termina-
tion or intermediate gene transcription initiation have led plasmids, to be used for transient dominant selection,
thus contained a mutant copy of D1R inserted upstreamto the conclusion that both the D1R and D12L subunits
are required for both reactions (Luo et al., 1995; Condit from and in the same transcriptional orientation as the
P7.5k promoter-driven ecogpt cassette. The presence ofet al., 1996).
The work described here had two major goals. First, the mutant sequence was confirmed by DNA sequencing
using a Sequenase Version 2.0 kit (U.S. Biochemical)we wished to test the generality of a previously described
method for targeted in vitro construction of vaccinia virus according to the manufacturer’s instructions. In the case
of mutant 793, the entire D1R open reading frame wastemperature-sensitive (ts) mutants using an unse-
lectable, essential gene. Second, we wished to observe sequenced in the clone to confirm that only the engi-
neered mutations were present.the phenotypic consequences of mutation of the vaccinia
capping enzyme. Pursuant to these goals, we have used
clustered charge-to-alanine mutagenesis and transient Transient dominant selection and D1R mutant screen
dominant selection to construct a ts mutation in the large
subunit of the vaccinia mRNA capping enzyme, and we Transient dominant selection was performed as pre-
viously described (Hassett and Condit, 1994; Falkner andhave characterized the effects of this mutation on both
the enzymatic activities of the enzyme in vitro and the Moss, 1990). Briefly, CV1 cells were pretreated with my-
cophenolic acid (MPA), infected with wild-type vacciniagrowth properties of the virus in vivo.
virus (m.o.i.  0.05 PFU per cell), transfected with 20 mg
of plasmid DNA using Transfectase (Life Technologies),MATERIALS AND METHODS
and incubated at 377 for 3 days in the presence of MPA.
Cells and viruses Following transfection, homologous recombination be-
tween D1R sequences on the plasmid and the viral chro-BSC40 cells and wild-type vaccinia virus strain WR,
mosome generates a recombinant virus that contains amethods for cell culture, wild-type (wt) and mutant virus
duplication of the D1R gene punctuated with the P7.5k–growth, plaque titration, one-step growth, and marker
ecogpt cassette. Infected, transfected cells were har-rescue have been described (Condit and Motyczka, 1981;
vested and plaque titrated on CV1 cells in the presenceCondit et al., 1983; Thompson and Condit, 1986). Wild-
of MPA. Five individual MPA-resistant plaques from eachtype vaccinia virus strain IHD-W and mutant ts9383 were
transfection were picked and plaque titrated on BSC40originally provided by Dr. G. McFadden (University of
cells at 317. To isolate viruses that have resolved theAlberta) and Dr. S. Dales (University of Western Ontario),
gene duplication and retained a mutant copy of D1R, 50respectively (Dales et al., 1978; Carpenter and Delange,
individual plaques, 10 from each original MPA-resistant1991).
plaque, were picked, then screened for temperature sen-
sitivity by replaquing at 317 and 407. Individual plaquesMutagenesis and cloning
from dishes showing either heterogeneity in plaque size
or reduced plaque size in comparison to wild type wereOligonucleotide-directed mutagenesis was performed
using the T7-GEN in vitro mutagenesis kit (U.S. Biochemi- re-plaque purified at 317 and grown as described above.
The D1R gene from mutant viral DNA was polymerasecal). Mutagenic oligonucleotides, synthesized by the Uni-
versity of Florida ICBR DNA Synthesis Core Laboratory, chain reaction (PCR) amplified, and appropriate selected
regions of D1R were sequenced and subjected to restric-were designed to include 12 nucleotides 5* and 9 nucleo-
tides 3* of the mismatched region (Bennett et al., 1991). tion enzyme analysis to confirm the presence of the de-
sired mutations (the 126, 326, and 793 mutations createThe phage M13mp18D1RNco0 (a gift from Dr. E. Niles,
SUNY Buffalo), used as a template for all mutagenesis novel NheI, NotI, and NheI restriction enzyme sites in
D1R, respectively, whereas the 516 mutation creates aexperiments, has been previously described (Higman et
al., 1994). Briefly, M13mp18D1RNco- is an M13mp18 new BbvI restriction site). Marker rescue experiments
showed that the temperature-sensitive phenotype of mu-phage containing the complete D1R open reading frame
into which a silent mutation disrupting an NcoI restriction tant 793 could be converted to wild type with a plasmid
clone containing only the D1R open reading frame, con-site has been engineered at nucleotide position /2235
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firming that the mutation responsible for the temperature were viewed on a Hitachi H7000 transmission electron
microscope. Fixation, embedding, staining, and micro-sensitivity of the 793 virus lies within the D1R gene (data
not shown). copy were done with the assistance of the University of
Florida ICBR Electron Microscopy Core Laboratory.
Protein synthesis
Telomere resolutionPulse labeling of infected cells with trans-35S label
(1153 Ci/mmol, ICN Biochemical), sodium dodecyl sul- Monolayers of BSC40 cells were infected at a m.o.i.
fate–polyacrylamide gel electrophoresis (SDS–PAGE), of 10 PFU per cell and incubated for 24 h at either 377
and autoradiography were done as previously described or 407. Intact cells were then embedded in agarose
(Condit and Motyczka, 1981). For pulse–chase experi- plugs and digested with XhoI as described previously
ments, pulse-labeled cells were washed and incubated (Delange et al., 1995). Specifically, the plugs were
in serum-containing medium for various times, then har- briefly heated at 707 to melt the agarose, then cooled
vested and analyzed as described above. to 407 and mixed with an enzyme – buffer mixture. Di-
gestions were allowed to proceed for 2 h at 407, and
Northern analysis the digested DNA was electrophoresed in a 0.7% agar-
ose gel. The DNA was then transferred to nylon filterConfluent monolayers of BSC40 cells on 100-mm
and probed with 32P-labeled plasmid p1369 (Parsonsdishes were infected at a m.o.i. of 15 and incubated at
and Pickup, 1990), which contains a terminal tandemeither 317 or 407. At various times postinfection, total
repeat insert of vaccinia virus.RNA was extracted with guanidinium isothiocyanate and
purified through CsCl density gradients (Ausubel et al.,
Virion purification1987). Northern transfer and hybridization were done as
previously described (Bayliss and Condit, 1993; Black Purification of vaccinia virus by sedimentation through
and Condit, 1996). Plasmids used to prepare antisense preformed discontinuous sucrose density gradients was
riboprobes specific for the vaccinia virus C11R, G8R, and done as previously described (Joklik, 1962). Purified viri-
F17R mRNA transcripts were a gift from A. Ramsey-Ewing ons were quantified by the Bradford assay (Bethesda
and B. Moss, and their construction and utilization have Research Laboratories) and optical density at 260 nm
been described elsewhere (Keck et al., 1990; Baldick et (1 OD260  64 mg virus). Infectivity of the purified virus
al., 1992). Briefly, the plasmids contain 678, 530, and 682 was assayed by plaque titration on BSC40 cells at 317.
nucleotides of coding sequence corresponding to the 5* There was no significant difference in either the quantity
ends of vaccinia virus genes C11R (early), G8R (interme- or infectivity of the 793 virus preparations compared with
diate), and F17R (late), respectively, each inserted into wild-type preparations.
the vector plasmid pGEM3ZF (Promega). The plasmids
were linearized by restriction enzyme digestion with Virion extract preparation
EcoRI (C11R and G8R) or BamHI (F17R) and transcribed
Enzyme extracts of purified virions were prepared es-in vitro with T7 RNA polymerase (Promega) to generate
sentially as described by Rohrman and Moss (1985). Puri-antisense RNA molecules of 316 (C11R), 300 (G8R), or
fied virus, 2.25 mg, was suspended in 250 ml buffer A126 (F17R) nucleotides in length. In vitro transcription
[0.1 M Tris–HCl, pH 8.0, 10 mM dithiothreitol (DTT), 250reactions were performed as described in the Promega
mM KCl, 0.2 mM EDTA], adjusted to 0.2% deoxycholate,manual.
and incubated on ice for 30 min with occasional mixing.
Insoluble material was removed by centrifugation andElectron microscopy
the viscosity of the supernatant was reduced by passage
Confluent monolayers of BSC40 cells on 100-mm
through a 23-gauge needle. The extract was applied to
dishes were infected with either wild type or 793 at a
a 0.5-ml column of DEAE-cellulose equilibrated in buffer
m.o.i. of 15 and incubated at either 317 or 407. At 36 h
A, and eluted with buffer A. The flow-through material
postinfection the cells were washed with 5 ml of phos-
was adjusted to 15% glycerol and stored in small aliquots
phate-buffered saline (PBS), then 1.5 ml of 2% glutaralde-
at 0707.
hyde in PBS was added to each dish, and dishes were
incubated at room temperature for 60 min with occa- Coupled transcription and methyltransferase assay
sional rocking. Cells were scraped from the dishes, pel- of permeabilized virions
leted at 700g for 5 min, resuspended in PBS, then stored
at 47 before further processing. The cells were collected Methyltransferase activity in permeabilized virions
was assayed by measuring transfer of the radiolabeledby centrifugation, postfixed in 1% osmium tetroxide, dehy-
drated in a graded series of ethanol solutions, and em- methyl group from S-adenosylmethionine to virion RNA
synthesized and guanylylated in the same reactions (Ger-bedded in Spurr’s epon resin mix. Following thin sec-
tioning, the samples were poststained in uranyl acetate showitz and Moss, 1979). Purified virions were preincu-
bated at 307, 357, or 407 in 100-ml reactions containingand Reynolds lead acetate. After mounting, the samples
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13 mg/ml virus, 0.1 M Tris–HCl (pH 8.5), 0.1% Nonidet P- resed on 10% SDS–polyacrylamide gels and the gels
were fixed, stained, destained, dried, and autoradio-40, 0.02 M DTT, and 0.02 M MgCl2 . At various times,
10-ml samples were removed and held on ice until the graphed. Incorporation of label into the 96-kDa D1R pro-
tein was quantified by phosphorimaging as describedconclusion of the preincubation time course. For the tran-
scription reactions 10 ml of a solution containing 10 mM above.
ATP, 2 mM GTP, 2 mM CTP, 0.66 mM unlabeled UTP,
Guanylyltransferase assaysand 0.2 mCi [3H]UTP (14 Ci/mmol, Amersham) was added
to each preincubated sample and reactions were incu- Guanylyltransferase activity was measured as de-
bated at 307 for 30 min. For methyltransferase reactions scribed by Shuman and Moss (1990). The substrate, a
10 ml of a solution containing 10 mM ATP, 2 mM GTP, 2 5*-triphosphorylated polyadenylate homopolymer ap-
mM CTP, 2 mM unlabeled UTP, and 0.66 mCi S-[3H]- proximately 200 residues in length, was synthesized as
adenosyl-L-methionine (15 Ci/mmol, Amersham) was described (Shuman and Moss, 1990). Varying amounts
added to each preincubated sample and reactions were of virion extract were incubated for 60 min at 307 or 377
incubated at 307 for 30 min. Following this incubation, 15 in 20-ml reactions containing 25 mM Tris–HCl, pH 8.0, 2
ml was removed from each reaction and spotted onto mM MgCl2 , 1 mM DTT, 25 mM GTP, 0.1 mM S-adenosyl-
DE81 filters (Whatman). Unincorporated radioactivity was methionine, 1.2 mCi [a-32P]GTP (3000 Ci/mmol, Amer-
removed by washing the filters in 0.5 M Na2HPO4 and sham), and 7 pmol 5*-triphosphorylated poly(A) substrate.
the filters were analyzed by liquid scintillation counting. Reactions were precipitated with 5% TCA, the precipi-
Wild-type and 793 transcription and methyltransferase tates were collected on glass-fiber filters, and the filters
reactions were normalized to identical reactions carried were analyzed by liquid scintillation counting.
out with virions that had not been preincubated and the
results expressed as the percentage of activity relative Nonspecific RNA polymerase assays in virion
to the nonpreincubated controls. extracts
Nonspecific RNA polymerase activity was assayed inUncoupled assay of methyltransferase in
virion extracts essentially as described by Baroudy andpermeabilized virions and virion extracts
Moss (1980). Varying amounts of virion extract were incu-
Methyl transfer to GTP in permeabilized virions or bated for 45 min at 307 or 377 in 25-ml reactions con-
in virion extracts was measured essentially as de- taining 50 mM Tris–HCl, pH 8.0, 4 mM MnCl2 , 2 mM
scribed by Shuman and Moss (1990). Purified virions DTT, 1 mM each ATP, GTP, and CTP, 8 mM [3H]UTP (10
at a concentration of 1.3 mg/ml were preincubated as Ci/mmol, Amersham), and 0.3 mg single-stranded M13
described above. Samples (12.5 ml) of preincubated DNA. Reactions were precipitated with 5% TCA, the pre-
virions were mixed with 12.5 ml of a solution containing cipitates were collected on glass-fiber filters, and the
10 mM GTP and 1 mM S-[3H]adenosyl-L-methionine (15 filters were analyzed by liquid scintillation counting.
Ci/mmol, Amersham) and incubated at 307 for 30 min.
Virion extracts were incubated in 25-ml reactions con- Western blot analysis
taining 50 mM Tris – HCl, pH 7.5, 1 mM DTT, 10 mM
Protein transfer to nitrocellulose following SDS–PAGE
GTP, and 1 mM S-[3H]adenosyl-L-methionine (15 Ci/
was done according to the method of Towbin et al. (1979).
mmol, Amersham), and reactions were incubated at
Polyclonal antiseras for D1R and D12L, kindly provided
307 for 30 min. In both cases, portions (20 ml) of each
by E. Niles and S. Shuman, respectively, were each used
sample were spotted on DE81 filters (Whatman); filters
at a dilution of 1:2000. The primary antibody was detected
were washed four times with 25 mM ammonium for-
by using horseradish peroxidase-linked polyclonal anti-
mate, once with water, and twice with ethanol, dried,
rabbit antiserum (Amersham) at a dilution of 1:10,000 and
and analyzed by liquid scintillation counting.
visualized using an Amersham enhanced chemilumines-
cence Western blotting kit according to the manufactur-Assay of enzyme–GMP (EpG) complex formation in
er’s instructions. In all cases, several different proteinpermeabilized virions and virion extracts
concentrations were tested to ensure that the Western
blot signal was proportional to the amount of test proteinThe formation of a covalent intermediate between the
D1R protein and GMP either in permeabilized virions or analyzed.
in virion extracts was assayed essentially as described
by Shuman and Moss (1990). Varying amounts of purified RESULTS
virions or virion extract were incubated for 10 min at 307
Construction of D1R mutant viruses
in 10-ml reactions containing 50 mM Tris–HCl, pH 8.2,
0.05% NP-40, 5 mM MgCl2 , 10 mM DTT, and 2 mCi We used clustered charge-to-alanine mutagenesis
and transient dominant selection to create temperature-[a-32P]GTP (3000 Ci/mmol, Amersham). Reactions were
stopped by the addition of 10 ml of twice-concentrated sensitive vaccinia virus mutants that affected the D1R
subunit of the capping enzyme. Ten charge clusters scat-SDS–PAGE loading buffer. Samples were electropho-
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tered throughout the D1R sequence were targeted for
mutagenesis (Fig. 1). Each cluster contained three or
four charged residues within a three- to six-amino acid
window, and in each case all of the charged residues
within a cluster were changed to alanines using oligo-
nucleotide-directed site-specific mutagenesis. These
cloned mutations were then inserted into the viral chro-
mosome using transient dominant selection. Specifically,
cells infected with wild-type virus were transfected with
a plasmid containing a mutant copy of D1R cloned adja-
cent to the E. coli guanine phosphoribosyltransferase
gene (ecogpt) under the transcriptional control of a vac-
cinia virus early/late P7.5k promoter. During infection–
transfection, homologous recombination occurs be-
tween D1R sequences on the plasmid and on the viral
chromosome. Integration of the transfected plasmid via
a single crossover generates a virus that contains the
P7.5k–ecogpt cassette flanked on either side by a wild-
FIG. 2. Plaque formation by wild-type and four D1R clustered chargetype and a mutant copy of D1R. Viral lysates containing
to alanine mutant viruses. Plaque assays were incubated at 317 or 407
these recombinants were plaqued in the presence of for 1 week and stained with crystal violet.
mycophenolic acid (MPA). Expression of ecogpt provides
all of the viruses within the infected cell with resistance
to MPA. During the growth of each MPA-resistant plaque, of the remaining six mutations; therefore, we assume
resolution occurs via recombination between the two these mutations confer either wild-type or lethal pheno-
copies of D1R, resulting in viruses that have lost the types. The plaque phenotypes of the four mutant viruses
ecogpt cassette and contain only a single copy of the fell into three distinct classes. At both temperatures, mu-
D1R gene. Each MPA-resistant plaque therefore contains tant 126 produced plaques that were distinguishably
a mixture of viruses, some of which contain a mutant smaller than wild type. Mutant 126 virus also showed a
copy of D1R originally derived from the transfected plas- slight (less than 2 log) reduction in titer at 407 compared
mid, and others that retain a wild-type copy of D1R. Previ- with 317. Mutant 326 showed a heterogeneous mixture
ous experiments in our laboratory indicate that on aver- of large and small plaques at both temperatures with no
age 11% of the total progeny within each MPA-resistant detectable decrease in titer at 407. Small plaque variants
plaque contains the mutation of interest (Hassett and of 326 that were re-plaque purified at 317 showed the
Condit, 1994). Five individual MPA-resistant plaques from same heterogeneity in subsequent plaque assays (data
each transfection were picked and plaque titrated in a not shown). The mutants 516 and 793 were both tempera-
secondary assay at 317 in the absence of drug to isolate ture sensitive for plaque formation at 407. Mutants 516
individual viruses that had lost the ecogpt gene and now and 793 showed 3 and 7 log reductions in titer, respec-
contained either a single wild-type or mutant copy of tively, at 407 when compared with 317 (data not shown).
D1R. Individual plaques from the secondary assay were Interestingly, although the 793 virus is profoundly temper-
picked and screened for plaque formation in a tertiary ature sensitive in a plaque assay, the plaques produced
assay at 317 and 407 to identify temperature-sensitive or at 317 are the same size as those produced by wild type
plaque morphology mutants. For each original transfec- virus at 317.
tion, a total of 50 plaques were screened for temperature
sensitivity, 10 from each of the 5 primary MPA-resistant One-step growth experiments
plaques. This procedure identifies only mutations that in
some way alter the plaque phenotype of the virus relative Because biochemical experiments designed to exam-
ine a virus infection in vivo are done at high m.o.i., onlyto wild type. Lethal mutations do not plaque in the sec-
ondary assay and are therefore lost, and mutations that mutants that are temperature sensitive under these con-
ditions are suitable for in vivo biochemical analysis. One-confer a wild-type phenotype are passed over in the ter-
tiary assay. step growth experiments were therefore done to deter-
mine if any of the four clustered charge-to-alanine mutant
viruses isolated were temperature sensitive for growthPlaque phenotypes of D1R mutant viruses
at a high m.o.i. (Fig. 3). BSC40 cells were infected with
either wt or mutant virus at a m.o.i. of 6 and incubatedFour of the ten mutant D1R genes yielded viruses that
were either temperature sensitive for plaque formation at either 317 or 407. Infected cells were harvested at
various times after infection and progeny viruses wereor that produced smaller plaques than wild type at 317
or 407 (Fig. 2). We failed to isolate viruses containing any quantified by plaque titration at 317. Wild type virus grown
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FIG. 3. One-step growth of wild-type and D1R mutant viruses. BSC40 cells were infected at a m.o.i of 6 at 317 and 407. Samples were taken at
various times postinfection and titered at 317.
at 317 or 407 showed a burst size of between 50 and 100 separated by SDS–PAGE, and detected by autoradiography
PFU per cell, with a maximum yield occurring between (Fig. 4). The normal pattern of viral protein synthesis can be
48 and 72 h postinfection. The mutants 126, 326, and 516 seen most clearly by examination of the wild-type infection
produced significantly less virus than wild type at both at 407. The shutoff of host protein synthesis and the appear-
temperatures. However, all of these viruses grew at least ance of viral early proteins are evident by 2 h postinfection.
as well at 407 compared with 317, and therefore none of Labeling of early viral proteins diminishes by 4–6 h postin-
these viruses are temperature sensitive for growth in this fection. Labeling of late proteins begins at 4 h and persists
assay. The remaining mutant, 793, is clearly temperature up to at least 24 h postinfection. The pattern of protein
sensitive for growth in a high-m.o.i. infection. At 317 the synthesis in a wild-type infection at 317 is slightly delayed
burst size of 793 is between 40 and 50 PFU per cell, due to the decreased growth temperature but is otherwise
similar to that of wild-type virus, while at 407 this mutant identical to that of wild-type infections carried out at 407. In
produces no infectious progeny. In summary, after the 793 infections representatives of all three classes of viral
screening the 10 clustered charge-to-alanine alleles of proteins are made in similar amounts at both 317 and 407.
D1R we have identified one mutant, 793, that meets all In the 793 infections there is a 2- to 4-h delay in the schedule
the criteria of a useful ts mutant, warranting further study. of protein synthesis at both 317 and 407 compared with wild-
Mutant 793 was therefore subjected to further phenotypic type infections; thus, the 793 mutant is slightly compromised
analysis to characterize the defect responsible for tem- for gene expression at both temperatures. Since the delay
perature sensitivity in vivo. in protein synthesis in 793 infected cells is similar at 407
and 317, it is unlikely that the delay alone accounts for the
Synthesis and processing of viral proteins in 793- temperature sensitivity of the 793 virus.
infected cells During the late stages of infection, coincident with vi-
rion morphogenesis, several vaccinia virion proteins areAs a first test to determine whether the 793 mutation
proteolytically processed (Moss, 1996; VanSlyke et al.,affected viral protein synthesis or the regulation of viral gene
1991). Processing of virion proteins in wt and 793-in-expression, we assayed the time course of protein synthesis
fected cells was assayed using a pulse–chase labelingin infected cells. Cells were infected with wt or 793 virus
protocol. In the same experiment described in Fig. 4,and incubated at 317 or 407, and proteins were pulse-labeled
at various times postinfection with 35S-labeled methionine, cells pulse labeled at 8 h postinfection were chased with
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FIG. 4. Protein synthesis in wild type and 793 infected cells. Cells were infected at 317 or 407, and pulse-labeled for 15 min with [35S]methionine.
Cells were harvested, and proteins were separated on a 10% SDS–polyacrylamide gel and autoradiographed. The autoradiograms are shown. The
infecting virus is indicated at the left, and the temperature of incubation is indicated at the top. The time of pulse labeling is indicated, in hours,
below each lane. Approximate molecular weights, in kilodaltons, are shown at the right of each gel.
unlabeled methionine, and at various times after initiation representing the appearance of the processed forms of
these proteins, 4a (62 kDa) and 4b (60 kDa). At both 317of the chase, samples were analyzed by SDS–PAGE and
autoradiography (Fig. 5). The most obvious indicator of and 407 in wt infected cells, processing of p4a and p4b
is evident within 2 h of the initiation of a chase andnormal proteolytic processing is the disappearance of
two bands of 102 and 72 kDa, representing the precursor continues through 16 h of chase. At 317, protein pro-
cessing in 793-infected cells is indistinguishable fromforms of the major virion proteins p4a and p4b, respec-
tively, and the accumulation of a new band at 60–62 kDa, wt infections. In 793 infections incubated at 407, protein
processing may be very slightly delayed as revealed by
the 2-h chase time point, but is otherwise indistinguish-
able from either wild type at 317 or 407 or 793 at 317.
Viral mRNA synthesis in 793-infected cells
The kinetics of mutant viral mRNA synthesis and the
relative quantity and structure of specific early, intermedi-
ate, and late mutant viral mRNAs was assessed by North-
ern blot analysis. Cells were infected with wt virus or
793 and incubated at 317 or 407, and total RNA was
isolated at various times postinfection. RNA was electro-
phoresed through formaldehyde–agarose gels, trans-
ferred to nylon membranes, and hybridized to well-char-
acterized early (C11R), intermediate (G8R), and late
(F17R) gene-specific antisense riboprobes (Fig. 6). The
early gene C11R encodes a 16-kDa vaccinia growth fac-
tor, the intermediate gene G8R encodes a 30-kDa late
gene transcription factor, and the late gene F17R en-
codes an 11-kDa DNA-binding virion core phosphopro-
tein (see Moss, 1996; Keck et al., 1990; Baldick et al.,FIG. 5. Viral protein processing in infected cells. Infected cells were
1992). Examination of the data for the wt infection revealspulse labeled at 8 h postinfection, then chased with an excess of
unlabeled amino acids for an additional 16 h. Cells were harvested, the normal pattern of mRNA synthesis in vaccinia-in-
and proteins were separated on a 10% SDS–polyacrylamide gel and fected cells. Hybridization of wt RNA to the early C11R
autoradiographed. The autoradiograms are shown. The infecting virus probe shows a discrete 1-kb transcript that can be de-
is indicated at the left, and the temperature of incubation is indicated
tected at both 317 and 407 as early as 1.5 h postinfection.at the top. The time of chase is indicated, in hours, below each lane.
At both temperatures, C11R mRNA peaks at 3 h postin-Approximate molecular weights, in kilodaltons, are shown at the right
of each gel. fection and decreases at late times, albeit slower at 317
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within discrete areas of the cytoplasm known as viral
factories or virosomes (Dales and Siminovitch, 1961;
Dales and Mosbach, 1968). Virosomes are recognizable
initially as areas of cytoplasm that contain a distinctly
low density of normal organelles and presumably contain
replicating viral DNA. The first step in morphogenesis is
the appearance of a crescent-shaped membrane within
and around the viroplasm. The crescent envelopes a por-
tion of the viroplasm, forming a spheroid-shaped imma-
ture particle that appears circular in thin section. The
immature particle matures into the characteristic brick-
shaped, intracellular mature virion. To assess viral mor-
phogenesis, electron micrographs were prepared at 36
h postinfection from wild-type and 793-infected cells
grown at 317 and 407 (Fig. 7). Cells infected with wt virus
FIG. 6. Northern analysis of viral RNA isolated from wild type or 793 at 317 or 407 or with 793 at 317 all present a similar,
infections. Northern blot analysis was done on total RNA isolated at normal appearance. Specifically, under these conditions,
the time indicated, in hours, above each lane. The virus and infection all cells contain crescents, immature virions, and mature
conditions are indicated at the top of the figure. Membranes were
virions. Cells infected with 793 at 407 present a distinctlyprobed with riboprobes specific for an early gene (C11R), an intermedi-
different appearance relative to the controls. While virtu-ate gene (G8R), or a late gene (F17R) as indicated to the left and
autoradiographed; an autoradiogram is shown. ally all of the cells infected with 793 at 407 contained
large amounts of viroplasm, immature particles were
seen in only about one-half of the cells and mature parti-
than at 407. The discrete size of early mRNA results from cles were observed only extremely rarely and then in
sequence-specific transcription initiation and termina- small numbers. A micrograph of one of the cells con-
tion. The hybridization of wt RNA to the G8R and F17R taining immature viral particles is shown in Fig. 7D.
probes reveals a smear that ranges in size from approxi- These results indicate that under nonpermissive condi-
mately 0.5 to 4 kb. The intermediate G8R RNA first ap- tions 793 is at least severely delayed in virion morpho-
pears at approximately 6 h postinfection and the signal genesis and may in fact be blocked at an intermediate
decreases in intensity at later times. The late F17R signal stage.
appears at 6–9 h postinfection, peaks at a later time than
Telomere resolutionthe intermediate RNA signal, and persists throughout the
12-h span of the experiment. The smearing of intermedi- The vaccinia genome is a linear duplex DNA molecule
ate and late mRNAs is due to the fact that unlike early featuring 12-kb inverted terminal repeats, numerous
transcripts, intermediate and late mRNAs are not termi- short direct repeat sequences within the repeats, and
nated at discrete sites and therefore possess heteroge- hairpin ends (Moss, 1996). Vaccinia DNA is replicated
neous 3* ends (Cooper et al., 1981; Mahr and Roberts, as head-to-head, tail-to-tail concatamers that, late during
1984). Qualitatively the pattern of mRNA synthesis in 793- infection, are resolved to unit-length monomers in a pro-
infected cells is virtually identical to that of wt infections, cess termed telomere resolution (Delange and McFad-
and we do not regard the small quantitative differences den, 1990; Traktman, 1990). Resolution requires late viral
observed as significant. Most importantly, there is no gene expression and specific cis-acting DNA sequences
obvious effect of temperature on 793 mRNA synthesis within the concatamer junction, but the specific vaccinia
compared with wt infections that could readily account genes involved have not been rigorously identified (De-
for the inability of the 793 virus to produce infectious lange and McFadden, 1987; Delange, 1989; Merchlinsky
progeny at 407. It is also noteworthy that the discrete and Moss, 1989a,b; Merchlinsky, 1990). A previously de-
size of the early transcripts and the appearance of the scribed temperature sensitive mutant, ts9383, that affects
G8R intermediate mRNA prove that the early transcription the small subunit of the vaccinia virus capping enzyme,
termination and intermediate transcription initiation activ- D12L, is capable of normal protein and DNA synthesis
ities of the 793 mRNA capping enzyme remain intact in but is defective in telomere resolution at 407 (Carpenter
vivo at both 317 and 407. and Delange, 1991). Characterization of ts9383 at 407
by electron microscopy revealed that the infected cells
Viral morphogenesis of 793
contain viroplasm and defective crescents, as well as a
few immature and noninfectious mature particles (DalesBecause we were unable to detect any defects in pro-
tein or mRNA metabolism that could account for the tem- et al., 1978). Because this mutation was in the mRNA
capping enzyme and, like 793, was defective in morpho-perature sensitivity of the 793 virus at 407 we chose to
examine viral morphogenesis in the 793 infections by genesis, it was of interest to determine if the 793 mutant
was also defective in telomere resolution.electron microscopy. Vaccinia morphogenesis occurs
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FIG. 7. Electron micrographs of BSC40 cells infected with wild-type or 793 virus at 317 and 407. Cells were infected at a m.o.i. of 15 and processed
for electron microscopy at 36 h postinfection. (A) wt, 317; (B) wt, 407; (C) 793, 317; (D) 793, 407. Arrowheads indicate examples of immature particles.
Arrows indicate examples of mature particles.
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FIG. 7—Continued
Resolution of poxvirus concatamers into unit-length with the restriction enzyme XhoI, which cuts within the
inverted repeat, generates two telomere-containing frag-monomers can be assayed by Southern blot analysis of
viral DNA isolated from infected cells (Merchlinsky and ments of 6 kb each. Cleavage of unresolved DNA conca-
tamers with XhoI generates a 12-kb fragment that con-Moss, 1989b). Cleavage of a mature monomeric genome
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tain equivalent amounts of both subunits of the capping
enzyme (Fig. 9B).
Analysis of 793 capping enzyme activities in
permeabilized virions
Treatment of purified vaccinia virions with NP40 per-
meabilizes the particle by removing the outer membrane,
but leaves the enzyme-containing core structurally and
functionally intact. Permeabilized virions are capable of
FIG. 8. Telomere resolution in wild-type and 793- and ts9383-infected
accurately carrying out all of the steps required for syn-cells at 377 and 407. Monolayers of BSC40 cells were infected at a
thesis and modification of early viral mRNA. We usedm.o.i. of 10 PFU/cell with IHD-W, ts9383, or 793 at either 377 or 407.
After 24 h of infection, DNA was digested with XhoI and analyzed by permeabilized virions to determine whether the 793 mu-
gel electrophoresis and Southern blotting using a concatemer junction tation affected two specific functions of the D1R protein,
probe (Materials and Methods). The 6-kb hairpin indicates the resolved (guanine-7-)methyltransferase and enzyme–guanylylate
terminal fragment, and the 12-kb dimer represents the unresolved in-
(EpG) formation.verted repeat fragment.
The virion (guanine-7-)methyltransferase activity was
first assayed in a coupled transcription/methyltransfer-
tains the concatamer junction. Total DNA was prepared ase reaction in which guanylylated transcripts synthe-
at 24 h postinfection from cells infected at either 377 sized by virions were transmethylated during synthesis
or 407 with wild type, 793, or the control virus ts9383. (Gershowitz and Moss, 1979). Temperature sensitivity of
[Infections done at 317 with wt, ts9383, and 793 yield the methyltransferase reaction was assessed by preincu-
results that are identical to those of 377 infections (data bating virions at various temperatures prior to the assay.
not shown).] DNA was cleaved with XhoI, electropho- We controlled for nonspecific temperature-induced dam-
resed through an agarose gel, transferred to a nylon age to the virions by measuring transcription as well as
membrane and hybridized to a radiolabeled plasmid that transmethylation. Permeabilized 793 virions were prein-
contains the concatamer junction (Fig. 8). The results cubated in the absence of ribonucleotides at either 307,
show that in a wt vaccinia infection, all of the DNA is 357, or 407 for periods up to 1 h. Samples were removed
present in monomeric (hairpin) form at 24 h postinfection at various times during the preincubation and each sam-
at either 377 or 407. In cells infected with the control virus
ts9383, only monomeric DNA is present at 377, while at
407 the majority of telomere DNA is present as dimers,
demonstrating an accumulation of concatameric DNA,
hence a defect in telomere resolution. Infections with
793 yield results identical to those of ts9383, demonstra-
ting that 793 is temperature sensitive for telomere resolu-
tion. This result was confirmed by pulse-field gel electro-
phoresis of undigested DNAs (Delange, 1989), which in
793 infections at 407 showed a ladder of oligomeric ge-
nomes characteristic of resolution-defective mutants
(data not shown).
Analysis of the D1R protein in 793 virions and virion
extracts
Before proceeding to a biochemical analysis of the
D1R protein in the 793 mutant, it was important to deter-
mine whether 793 virions and extracts thereof contained
normal amounts of the D1 protein. Analysis of a Coomas-
sie blue-stained SDS–polyacrylamide gel of purified
FIG. 9. SDS–PAGE and Western blot analysis of purified wt and
wild-type and 793 virions (Fig. 9A) demonstrates that 793 virions and virion extracts. (A) Purified virions were analyzed by
there is no detectable difference in the pattern or quantity electrophoresis through a 10% SDS–polyacrylamide gel and stained
with Coomassie blue (Coomassie) or Western blotted and probed withof proteins present in the 793 virions relative to wild type.
polyclonal antiserum to D1R (anti-D1R) or D12L (anti-D12L). (B) FourWestern blot analysis with either anti-D1R or anti-D12L
micrograms of wt or 793 virion extract was electrophoresed through aantiserum confirms that 793 virions produced at 317 con-
10% SDS–polyacrylamide gel, Western blotted, and probed with a mix-
tain wild-type levels of capping enzyme (Fig. 9A). Like- ture of polyclonal antiserum to D1R or D12L. The identity of the extract
wise, Western blot analysis of extracts of wt and 793 is indicated above each lane, and the positions of the D1R and D12 L
proteins are indicated at the right.virions revealed that equivalent amounts of extract con-
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FIG. 10. Temperature sensitivity of in vitro transcription and methyltransferase activity in wild-type and 793 virions. Purified vaccinia virus virions
were preincubated at 307, 357, or 407. At 15-min intervals samples were removed and subsequently assayed for both transcription and methyltransfer-
ase as described under Materials and Methods. (A) and (B) represent coupled transcription/methyltransferase assays done on the same preparation
of preincubated virions. (C) Uncoupled methyl transfer to a GTP acceptor done in a separate assay. (A) Transcription. 100% values: wt  6029 cpm;
793  11,300 cpm. (B) Coupled methyltransferase. 100% values: wt  1616 cpm; 793  2101 cpm. (C) Uncoupled methyltransferase. 100% values:
wt  6.57 pmol; 793  3.71 pmol.
ple was then assayed for either methyltransferase or of transcription activity (Fig. 10B). Preincubation of 793
virions at 307 for up to 1 h results in no significant losstranscription activity at 307. Methyltransferase activity
was assayed by following the incorporation of radiola- of methyltransferase activity. In contrast, preincubation
of 793 virions at 357 or 407 results in a significant de-beled methyl groups from S-adenosylmethionine into
acid-insoluble material, and viral transcription was as- crease in methyltransferase activity; after 1 h of preincu-
bation at 407, less than 10% of the control methyltransfer-sayed by following the incorporation of radiolabeled UTP.
The results were normalized to assays done with either ase activity remains.
In the coupled transcription/methyltransferase reac-wild-type or mutant virions that had not been preincu-
bated (Fig. 10). The mutant and wild-type thermal inacti- tion described above, successful transmethylation de-
pends not only on efficient transcription, but also onvation profiles for transcription are similar at all tempera-
tures assayed (Fig. 10A). These results indicate that the guanylylation of the transcribed RNA, which was not
measured. We therefore assayed (guanine-7-)methyl-transcription apparatus packaged within 793 virions is
relatively thermostable and any significant thermolability transferase activity directly and we measured EpG forma-
tion as an indication of guanylyltransferase activity. Tem-associated with methyltransferase activity is not due to
lack of an mRNA substrate. Preincubation of wild-type perature sensitivity of the (guanine-7-)methyltransferase
activity in permeabilized virions was measured using avirions at 307, 357, or 407 for up to 1 h results in a slow
loss of methyltransferase activity which parallels the loss preincubation protocol identical to that described in Figs.
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presence of Mn2/. The results (Fig. 12) demonstrated
that equal amounts of wt or 793 virion extract contained
approximately equal amounts of RNA polymerase activ-
ity. Taken together with the Western blot analysis of cap-
ping enzyme protein (Fig. 9B), these results show that
extracts of wt and 793 virions were equivalent with re-
spect to protein composition and that enzymes that were
FIG. 11. Enzyme guanylylate formation in virions and virion extracts.
not directly affected by the 793 mutation functioned nor-Varying amounts of permeabilized virions or virion extracts were incu-
mally in 793 extracts.bated with [a-32P]GTP and analyzed by SDS–PAGE, autoradiography,
EpG formation was tested using the same assay usedand phosphorimage analysis as described under Materials and Meth-
ods. The regions of the autoradiograms containing the radiolabeled for permeabilized virions. Phosphorimage analysis of the
D1R protein are shown. The origin of protein (virion or extract) is indi- results (Fig. 11) shows that when equal amounts of solu-
cated at the left, the virus used is indicated at the top, and the amount
bilized wt and 793 D1R protein are tested for EpG forma-of protein assayed is shown below each lane, in micrograms.
tion, the 793 protein displays approximately 13% of the
wild-type level of activity. Thus, EpG formation is signifi-
cantly reduced in the 793 mutant, and interestingly, the10A and 10B, except that exogenously added GTP was
reduction in activity is more pronounced in extracts ofused as the methyl acceptor instead of endogenously
virions compared with permeabilized virions.synthesized RNA. The results (Fig. 10C) show that wt
Extracts of wt and 793 virions were tested for guanylyl-methyltransferase activity is stable to preincubation at
transferase activity using an assay that measures trans-temperatures as high as 407 for as long as 45 min. By
fer of label from [a-32P]GTP to a 5*-triphosphorylated po-contrast, 793 methyltransferase activity decreases to 70%
ly(A) substrate. Reaction conditions were first optimizedof control values within 15 min of preincubation at 307,
with respect to time of incubation and substrate concen-while preincubation of 793 virions at 357 or 407 results in
tration using wt extracts, then varying amounts of wtloss of greater than 80% of the control methyltransferase
and 793 extracts were compared for guanylyltransferaseactivity. These results are consistent with the results of
activity in reactions done at both 307 and 377 (Fig. 13). Thethe coupled transcription/transmethylation assay, and
results show that the 793 extracts contain no detectablethey show clearly that the (guanine-7-)methyltransferase
guanylyltransferase activity.activity in 793 virions is thermosensitive.
Extracts of wt and 793 virions were tested for methyl-To determine whether any other activities of the D1R
transferase activity using the same assay describedprotein were affected by the 793 mutation, we assayed
above, namely, transfer of methyl label from S-adenosyl-EpG formation in permeabilized virions. Varying amounts
methionine to a GTP acceptor. Reaction conditions wereof wt and 793 virions were incubated with [a-32P]GTP at
first optimized with respect to time of incubation and307, and EpG complexes were resolved by SDS–PAGE
substrate concentration using wt extracts, then varyingand autoradiography (Fig. 11). Phosphorimage analysis
amounts of wt and 793 extracts were compared for meth-of the complexes shows that per unit mass, the D1R
yltransferase activity in reactions done at both 307 andprotein in 793 virions is approximately 32% as active in
377 (Fig 14). The results show that the 793 extracts con-EpG complex formation compared with wt enzyme. Thus,
tain no detectable methyltransferase activity.the ability of the 793 D1 protein to catalyze of EpG com-
plex formation in permeabilized virions is significantly
reduced relative to wt enzyme.
Analysis of 793 capping enzyme activities in virion
extracts
The observation that both EpG formation and methyl-
transferase activities were compromised in 793 virions
raised the possibility that additional properties of the D1R
protein were affected by the 793 mutations. We therefore
assayed EpG formation, guanylyltransferase, and (gua-
nine-7-) methyltransferase in soluble extracts of purified
virions.
To ensure that solubilization of enzymes was equiva-
lent for wt and 793 virions, virion extracts were first as-
FIG. 12. Nonspecific RNA polymerase activity in wt and 793 virionsayed for RNA polymerase activity using a nonspecific
extracts. Varying amounts of wt and 793 extract were assayed for
transcription assay. Varying amounts of extract were incorporation of [3H]UTP into acid-insoluble material in the presence
tested for incorporation of radiolabeled UTP into RNA in of Mn2/ using single-stranded DNA as a template, as described under
Materials and Methods.reactions programmed with single-stranded DNA in the
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charge-to-alanine mutations to conserved regions within
the yeast capping enzyme resulted in an efficient recov-
ery of temperature-sensitive mutations in that system
(Schwer and Shuman, 1996).
It is important to note that we apply stringent and very
practical criteria in determining whether a particular vac-
cinia mutant is useful for extensive study. Specifically, a
useful mutant must be temperature sensitive in a high-
m.o.i., one-step growth experiment, since these are the
conditions employed for the in vivo analysis of the mu-
tant. It is particularly noteworthy that plaque assays ap-
parently do not substitute for this selection criterion. In
our experiments with the vaccinia gene G2R we found
FIG. 13. Guanylyltransferase activity in wt and 793 virion extracts. mutants that were temperature sensitive in a one-step
Varying amounts of wt and 793 virion extract were assayed for transfer
growth experiment but not in a plaque assay, and in theof [a-32P]GTP to a 5*-triphosphorylated poly(A) RNA substrate, as de-
experiments reported here with D1R, we found mutantsscribed under Materials and Methods.
that were temperature sensitive in a plaque assay but
not in a one-step growth experiment. The reasons for
DISCUSSION these apparent anomalies are not clear, but they serve to
emphasize the importance of using the one-step growthThe goal of this work was to create a temperature-
experiment as the ultimate screen for temperature-sensi-sensitive mutant of vaccinia virus that affected the large
tive mutants.subunit of the multifunctional vaccinia virus mRNA cap-
ping enzyme, to study what effect loss of capping enzyme Biochemistry of the 793 D1R protein
function has on the vaccinia virus life cycle. Equally im-
The 793 mutation is in the carboxyl terminus of D1Rportant, these experiments were designed to confirm the
in a region of the protein previously reported to be re-general applicability of clustered charge-to-alanine muta-
quired for (guanine-7-)methyltransferase activity and di-genesis and transient dominant selection as a directed
merization of D1R with D12L (Cong and Shuman, 1992;genetic method for the creation of temperature-sensitive
Higman et al., 1994; Mao and Shuman, 1994, 1996; Hig-vaccinia virus mutants. The isolation and in vivo charac-
man and Niles, 1994). We therefore anticipated that theterization of the 793- temperature-sensitive virus con-
mutation would affect the methyltransferase activity offirms that viral mutants amenable to in vivo study can
the enzyme. Consistent with this prediction, the methyl-be created by applying this directed genetic method to
transferase activity present in purified virions is thermo-vaccinia virus. Surprisingly, despite the fact that the 793
sensitive. Interestingly, solubilization of the enzyme frommutation clearly affected both the methyltransferase and
virions results in a preparation that lacks methyltransfer-guanylyltransferase activities of the capping enzyme, vi-
ase activity entirely, even at a low temperature at whichral protein synthesis and mRNA expression all appeared
the same enzyme contained in virions is still active. Thus,normal in the 793 infections at 407, while telomere resolu-
the ordered structure of the virion core probably stabi-tion and virion morphogenesis were defective.
lizes the conformation of the enzyme at low temperature,
Mutagenesis and mutant isolation
Published reports concerning isolation of temperature-
sensitive mutations in both yeast and viruses using clus-
tered charge-to-alanine mutagenesis led us to expect
that approximately 30% of mutations tested would yield
temperature-sensitive viruses (Wertman et al., 1992; Dia-
mond and Kirkegaard, 1993). Our prior experience with
the G2R gene of vaccinia was consistent with this expec-
tation: three of nine clustered charge-to-alanine muta-
tions in the G2R gene were temperature sensitive in a
one-step growth assay (Hassett and Condit, 1994). Al-
though we recovered only one useful ts mutant from
10 mutations tested in the D1R protein, our experience
dictates that this is still an acceptable rate for use of the
FIG. 14. Methyltransferase activity in wt and 793 virion extracts.
technique as a routine tool for vaccinia genetics. It is Varying amounts of wt and 793 virion extract were assayed for transfer
likely that the efficiency of the technique can and will be of C3H3 from [3H]methyl-SAM to GTP, as described under Materials
and Methods.improved. It is noteworthy, for example, that targeting
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and either high temperature or disruption of the core and mRNAs show no obvious defect in stability. Protein
synthesis in 793 infections is sluggish at both permissivestructure causes the protein to assume an inactive con-
formation. Such a conformational change may affect the and nonpermissive temperatures, which could indicate
a defect in mRNA template activity, but since this defectmethyltransferase active site directly, or, since the 793
mutation neutralizes a charge cluster within the D1R – was not specific to the nonpermissive temperature, it
does not readily account for the overall temperature sen-D12L interaction domain, the association between the
D1R and D12L subunits may be compromised. sitivity of the virus infection.
There are two possible explanations for the observa-The 793 mutation affects not only the methyltransfer-
ase activity of the protein but also EpG formation and tion that mRNA metabolism is apparently normal during
a 793 infection in vivo while the 793 capping enzyme isguanylyltransferase activity. Interestingly, the efficiency
of EpG formation is measurably lower in solubilized virion clearly defective in both methyltransferase and guanylyl-
transferase activities in vitro. First, a cellular enzyme mayextracts compared with permeabilized virions. Since EpG
formation requires only the D1R protein and not the D12L complement the 793 mutation in vivo. For example, a
cytoplasmic (guanine-7)-methyltransferase activity hassubunit (Shuman and Morham, 1990; Higman et al.,
1992), this observation supports the idea that the D1R been isolated from HeLa cells, and a similar enzymatic
activity in BSC40 cells could compensate for a vacciniaprotein itself assumes a less active conformation on sol-
ubilization from virions. It is not entirely clear whether capping enzyme defect in vivo (Ensinger and Moss,
1976). Second, it is possible that the 793 enzyme is some-the observed lack of guanylyltransferase activity, that is,
the inability to transfer GMP from EpG to RNA, is a direct how stabilized in vivo or that only a trickle of activity is
required to sustain a level of mRNA metabolism andconsequence of reduced EpG formation, or if both EpG
formation and guanylyl transfer are compromised in the protein synthesis that by our relatively gross measure-
ments appears normal. Given the multiple highly special-solubilized enzyme. However, guanylyltransferase activ-
ity was consistently at or below background levels for ized functions of the vaccinia capping enzyme and the
fact that more than one of these activities is defectivethe assay, whereas EpG formation by the 793 protein
was always at least 10% of wt activity, indicating that in in vitro, complementation by a cellular enzyme seems
unlikely, and we therefore favor the second hypothesis.fact both EpG formation and guanylyltransferase activi-
ties are affected by the 793 mutation. This conclusion sounds a loud note of caution in interpre-
ting results obtained with viral mutants: the in vivo pheno-Numerous published reports show that the guanylyl-
transferase and methyltransferase activities of the D1R type of a particular mutant may not always provide a clear
or accurate representation of the biochemical function ofprotein occupy discrete and physically separable do-
mains within the protein (Shuman and Morham, 1990; the gene in question. An important lesson from these
experiments, therefore, is that wherever possible multi-Niles et al., 1994; Higman et al., 1992, 1994; Myette and
Niles, 1996). We therefore expected that any mutation ple alleles from any given gene should be analyzed be-
fore drawing firm conclusions about the biochemical rolethat affected one activity would not necessarily affect
the other. In contrast, the 793 mutation affects both the of the gene in vivo.
During the phenotypic analysis of the 793 mutant, theguanylyltransferase and methyltransferase activities. A
likely explanation for this observation is that the 793 mu- only defects that were observed that might account for
temperature-sensitive growth of the virus were deficienciestation promotes a dramatic conformational change in the
D1R protein akin to denaturation, thus affecting active in telomere resolution and in virion morphogenesis. There
exist three possible explanations for these observations.sites in widely separated domains. This explanation is
supported by the experiments discussed above which First, the inability of 793 to resolve telomeres and undergo
morphogenesis at 407 could be a pleiotropic effect of theshow that solubilization of the D1R protein from virions
further damages an already crippled enzyme. loss of capping enzyme function. Second, the capping en-
zyme may be directly involved in virion morphogenesis, and
this defect may indirectly affect telomere resolution. Third,Phenotype
the capping enzyme may be directly involved in telomere
resolution, and this defect may indirectly affect virion mor-Based on the known role of the vaccinia virus mRNA
capping enzyme in mRNA capping, early gene transcrip- phogenesis. Several observations support the first alterna-
tive. Previous studies have shown that most of the tempera-tion termination, and intermediate gene transcription ini-
tiation, we fully expected that the 793 mutation would ture-sensitive mutants classified as being unable to resolve
telomeres under nonpermissive conditions have a corre-affect some aspect of viral mRNA metabolism in vivo.
To our surprise, however, our analysis of viral protein sponding defect in late viral protein synthesis (Merchlinsky
and Moss, 1989b; Delange, 1989). This observation has ledsynthesis and transcription revealed no defect in 793
infections that could account for the temperature sensi- to the conclusion that one or more of the enzymes required
for resolution are the products of intermediate or late genes.tivity observed in a one-step growth experiment. Specifi-
cally, both the early transcription termination and inter- Late protein synthesis is clearly required for morphogene-
sis because structural components of the virion particle aremediate transcription initiation functions remain intact,
AID VY 8820 / 6a53$$$401 10-29-97 11:02:57 viral AP: VY
407VACCINIA CAPPING ENZYME ts MUTANT
encoded by late genes. Thus, the 793 mutation may in fact ACKNOWLEDGMENTS
cause an undetected reduction in the amount of translat- We thank Ed Niles and Stewart Shuman for reagents, for helpful
able mRNA and, consequently, a slight, undetected reduc- discussions while this work was in progress, and for their careful
reading of the manuscript. We thank the University of Florida ICBRtion in the quantity of one or several late proteins required
DNA synthesis and electron microscopy core laboratories for oligonu-for telomere resolution and virion morphogenesis. The sec-
cleotides and electron microscopy. This work was supported by Na-ond possibility is supported by recent observations that a tional Institutes of Health Grant AI18094 to R.C.C. and by a grant from
conditional null mutation in vETF, the viral early transcrip- the Medical Research Council of Canada to L.D.
tion initiation factor, elicits a morphogenesis phenotype in
REFERENCESinfected cells (Hu et al., 1996). Thus, as suggested by Hu
et al. (1996) for vETF, the capping enzyme may play a direct Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G.,
role in morphogenesis or it may be required for expression Smith, J. A., and Struhl, K. (1987). ‘‘Current Protocols in Molecular
Biology.’’ Wiley, New York.of a subset of genes, for example, reactivated early genes
Baldick, C. J., Jr., Keck, J. G., and Moss, B. (1992). Mutational analysis(Garces et al., 1993) or putative very late genes (Hu et al.,
of the core, spacer, and initiator regions of vaccinia virus intermedi-
1996), which are required for morphogenesis. The third ate-class promoters. J. Virol. 66, 4710–4719.
possibility is discussed below. Baroudy, B. M., and Moss, B. (1980). Purification and characterization
of a DNA-dependent RNA polymerase from vaccinia virions. J. Biol.Based on observations of ts9383, a vaccinia mutant
Chem. 255, 4372–4380.that maps to the small subunit of the mRNA capping
Bayliss, C. D., and Condit, R. C. (1993). Temperature-sensitive mutantsenzyme and that bears a striking phenotypic similarity
in the vaccinia virus A18R gene increase double-stranded RNA syn-
to 793, DeLange and co-workers have argued that the thesis as a result of aberrant viral transcription. Virology 194, 254–
capping enzyme plays a direct role in telomere resolution 262.
Bennett, W. F., Paoni, N. F., Keyt, B. A., Botstein, D., Jones, A. J. S.,(Carpenter and Delange, 1991). Telomere resolution may
Presta, L., Wurm, F. M., and Zoller, M. J. (1991). High resolution analy-be viewed as a site-specific recombination that requires
sis of functional determinants on human tissue-type plasminogen
a putative DNA resolvase and two inverted cis-acting activator. J. Biol. Chem. 266, 5191–5201.
sequences termed the telomere resolution targets. Muta- Black, E. P., and Condit, R. C. (1996). Phenotypic characterization of
mutants in vaccinia virus gene G2R, a putative transcription elonga-tional analysis has clearly defined the nature of the cis-
tion factor. J. Virol. 70, 47–54.acting sequences but there as yet have been no pub-
Carpenter, M. S., and Delange, A. M. (1991). A temperature-sensitivelished data on the identity of the putative DNA resolvase
lesion in the small subunit of the vaccinia virus-encoded mRNA cap-
(Delange and McFadden, 1987; Merchlinsky and Moss, ping enzyme causes a defect in viral telomere resolution. J. Virol. 65,
1989a; Merchlinsky, 1990; Stuart et al., 1992). It is note- 4042–4050.
Condit, R. C., and Motyczka, A. (1981). Isolation and preliminary charac-worthy in light of the function of the capping enzyme
terization of temperature-sensitive mutants of vaccinia virus. Virologyas an intermediate transcription factor that the telomere
113, 224–241.
resolution targets function as a promoter during the latter Condit, R. C., Motyczka, A., and Spizz, G. (1983). Isolation, characteriza-
stages of the vaccinia replication cycle (Stuart et al., tion, and physical mapping of temperature-sensitive mutants of vac-
cinia virus. Virology 128, 429–443.1991; Parsons and Pickup, 1990; Hu and Pickup, 1991).
Condit, R. C., Lewis, J. I., Quinn, M., Christen, L. M., and Niles, E. G.It has been proposed that binding of the transcription
(1996). Use of lysolecithin-permeabilized infected-cell extracts to in-machinery to the telomere resolution targets or the telo-
vestigate the in vitro biochemical phenotypes of poxvirus ts muta-
meric RNAs themselves may play a role in the resolution tions altered in viral transcription activity. Virology 218, 169–180.
event (Parsons and Pickup, 1990; Stuart et al., 1991; Hu Cong, P., and Shuman, S. (1992). Methyltransferase and subunit associ-
ation domains of vaccinia virus mRNA capping enzyme. J. Biol. Chem.and Pickup, 1991; Carpenter and Delange, 1991). Thus,
267, 16424–16429.a transcription complex containing a defective capping
Cong, P., and Shuman, S. (1993). Covalent catalysis in nucleotidyl trans-
enzyme could directly affect the resolution event, through fer. A KTDG motif essential for enzyme–GMP complex formation by
a specific defect in transcriptional activity or a defect in mRNA capping enzyme is conserved at the active sites of RNA and
DNA ligases. J Biol. Chem. 268, 7256–7260.mRNA stability.
Cong, P., and Shuman, S. (1995). Mutational analysis of mRNA cappingLastly, a defect in telomere resolution could theoreti-
enzyme identifies amino acids involved in GTP binding, enzyme–cally cause a defect in virion morphogenesis. While te-
guanylate formation, and GMP transfer to RNA. Mol. Cell. Biol. 15,
lomere resolution in vivo is not inhibited by rifampicin, 6222–6231.
an inhibitor of poxvirus morphogenesis (Merchlinsky and Cooper, J. A., Wittek, R., and Moss, B. (1981). Extension of the transcrip-
tional and translational map of the left end of the vaccinia virusMoss, 1989b), it is formally possible that resolution of
genome to 21 kilobase pairs. J. Virol. 39, 733–745.concatamers to unit length viral genomes is a prerequi-
Dales, S., and Mosbach, E. (1968). Vaccinia as a model for membrane
site for efficient virion morphogenesis. biogenesis. Virology 35, 546–583.
Future studies of the 793 mutation may yield additional Dales, S., and Siminovitch, L. (1961). The development of vaccinia virus
in Earle’s L strain cells as examined by electron microscopy. J. Bio-insights into the biochemistry of the vaccinia virus cap-
phys. Biochem. Cytol. 10, 475–503.ping enzyme and its role during virus infection. In addi-
Dales, S., Milovanovitch, V., Pogo, B. G., Weintraub, S. B., Huima, T.,tion, future application of clustered charge-to-alanine Wilton, S., and McFadden, G. (1978). Biogenesis of vaccinia: Isolation
mutagenesis will prove valuable in studying the capping of conditional lethal mutants and electron microscopic characteriza-
tion of their phenotypically expressed defects. Virology 84, 403–428.enzyme and many other vaccinia genes.
AID VY 8820 / 6a53$$$402 10-29-97 11:02:57 viral AP: VY
408 HASSETT ET AL.
Delange, A. M. (1989). Identification of temperature-sensitive mutants Mahr, A., and Roberts, B. E. (1984). Arrangement of late RNAs tran-
scribed from a 7.1-kilobase EcoRI vaccinia virus DNA fragment. J.of vaccinia virus that are defective in conversion of concatemeric
replicative intermediates to the mature linear DNA genome. J. Virol. Virol. 49, 510–520.
Mao, X., and Shuman, S. (1994). Intrinsic RNA (guanine-7) methyltrans-63, 2437–2444.
Delange, A. M., and McFadden, G. (1987). Efficient resolution of repli- ferase activity of the vaccinia virus capping enzyme D1 subunit is
stimulated by the D12 subunit: Identification of amino acid residuescated poxvirus telomeres to native hairpin structures requires two
inverted symmetrical copies of a core target DNA sequence. J. Virol. in the D1 protein required for subunit association and methyl group
transfer. J Biol. Chem. 269, 24472–24479.61, 1957–1963.
Delange, A. M., and McFadden, G. (1990). The role of telomeres in Mao, X., and Shuman, S. (1996). Vaccinia virus mRNA (guanine-7-)meth-
yltransferase: Mutational effects on cap methylation and AdoHcy-poxvirus DNA replication. Curr. Top. Microbiol. Immunol. 163, 71–
92. dependent photo-cross-linking of the cap to the methyl acceptor site.
Biochemistry 35, 6900–6910.Delange, A. M., Carpenter, M. S., Choy, J., and Newsway, V. E. (1995).
An etoposide-induced block in vaccinia virus telomere resolution Martin, S. A., Paoletti, E., and Moss, B. (1975). Purification of mRNA
guanylyltransferase and mRNA (guanine-7-) methyltransferase fromis dependent on the virus-encoded DNA ligase. J Virol. 69, 2082–
2091. vaccinia virions. J. Biol. Chem. 250, 9322–9329.
Merchlinsky, M. (1990). Mutational analysis of the resolution sequenceDiamond, S. E., and Kirkegaard, K. (1993). Clustered charge-to-alanine
mutagenesis of poliovirus RNA-dependent RNA polymerase yields of vaccinia virus DNA: Essential sequence consists of two separate
AT-rich regions highly conserved among poxviruses. J. Virol. 64,multiple temperature-sensitive mutants defective in RNA synthesis.
J. Virol. 68, 863–876. 5029–5035.
Merchlinsky, M., and Moss, B. (1989a). Nucleotide sequence requiredEnsinger, M. J., and Moss, B. (1976). Modification of the 5* terminus of
mRNA by an RNA (guanine-7-)-methyltransferase from HeLa cells. J for resolution of the concatemer junction of vaccinia virus DNA. J.
Virol. 63, 4354–4361.Biol. Chem. 251, 5283–5291.
Ensinger, M. J., Martin, S. A., Paoletti, E., and Moss, B. (1975). Modifica- Merchlinsky, M., and Moss, B. (1989b). Resolution of vaccinia virus
DNA concatemer junctions requires late-gene expression. J. Virol.tion of the 5*-terminus of mRNA by soluble guanylyl and methyl
transferases from vaccinia virus. Proc. Natl. Acad. Sci. USA 72, 2525– 63, 1595–1603.
Morgan, J. R., Cohen, L. K., and Roberts, B. E. (1984). Identification of2529.
Falkner, F. G., and Moss, B. (1990). Transient dominant selection of the DNA sequences encoding the large subunit of the mRNA-capping
enzyme of vaccinia virus. J. Virol. 52, 206–214.recombinant vaccinia viruses. J. Virol. 64, 3108–3111.
Garces, J., Masternak, K., Kunz, B., and Wittek, R. (1993). Reactivation Moss, B. (1996). In ‘‘Fields Virology’’ (B. N. Fields, D. M. Knipe, P. M.
Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, andof transcription from a vaccinia virus early promoter late in infection.
J. Virol. 67, 5394–5401. S. E. Strauss, Eds.), 3rd ed., pp. 2637–2672. Lippincott-Raven, New
York.Gershowitz, A., and Moss, B. (1979). Abortive transcription products of
vaccinia virus are guanylylated, methylated, and polyadenylylated. J. Myette, J. R., and Niles, E. G. (1996). Domain structure of the vaccinia
virus mRNA capping enzyme: Expression in Escherichia coli of aVirol. 31, 849–853.
Guo, P. X., and Moss, B. (1990). Interaction and mutual stabilization of subdomain possessing the RNA 5*-triphosphatase and guanylyltrans-
ferase activities and a kinetic comparison to the full-size enzyme. J.the two subunits of vaccinia virus mRNA capping enzyme coex-
pressed in Escherichia coli. Proc. Natl. Acad. Sci. USA 87, 4023– Biol. Chem. 271, 11936–11944.
Niles, E. G., and Christen, L. (1993). Identification of the vaccinia virus4027.
Hassett, D. E., and Condit, R. C. (1994). Targeted construction of tem- mRNA guanyltransferase active site lysine. J. Biol. Chem. 268, 24986–
24989.perature-sensitive mutations in vaccinia virus by replacing clustered
charged residues with alanine. Proc. Natl. Acad. Sci. USA 91, 4554– Niles, E. G., Condit, R. C., Caro, P., Davidson, K., Matusick, L., and Seto,
J. (1986). Nucleotide sequence and genetic map of the 16-kb vaccinia4558.
Higman, M. A., and Niles, E. G. (1994). Location of the S-adenosyl-L- virus HindIII D fragment. Virology 153, 96–112.
Niles, E. G., Lee Chen, G. J., Shuman, S., Moss, B., and Broyles, S. S.methionine binding region of the vaccinia virus mRNA (guanine-7-)
methyltransferase. J Biol. Chem. 269, 14982–14987. (1989). Vaccinia virus gene D12L encodes the small subunit of the
viral mRNA capping enzyme. Virology 172, 513–522.Higman, M. A., Bourgeois, N., and Niles, E. G. (1992). The vaccinia virus
mRNA (guanine-N7-)-methyltransferase requires both subunits of the Niles, E. G., Christen, L., and Higman, M. A. (1994). Direct photolinkage
of GTP to the vaccinia virus mRNA (guanine-7-) methyltransferasemRNA capping enzyme for activity. J. Biol. Chem. 267, 16430–16437.
Higman, M. A., Christen, L. A., and Niles, E. G. (1994). The mRNA (gua- GTPmethyl acceptor site. Biochemistry 33, 9898–9903.
Parsons, B. L., and Pickup, D. J. (1990). Transcription of orthopoxvirusnine-7-)methyltransferase domain of the vaccinia virus mRNA cap-
ping enzyme: Expression in Escherichia coli and structural and ki- telomeres at late times during infection. Virology 175, 69–80.
Rohrmann, G., and Moss, B. (1985). Transcription of vaccinia virus earlynetic comparison to the intact capping enzyme. J Biol. Chem. 269,
14974–14981. genes by a template-dependent soluble extract of purified virions. J.
Virol. 56, 349–355.Hu, F. Q., and Pickup, D. J. (1991). Transcription of the terminal loop
region of vaccinia virus DNA is initiated from the telomere sequences Schwer, B., and Shuman, S. (1996). Conditional inactivation of mRNA
capping enzyme affects yeast pre-mRNA splicing in vivo. RNA 2,directing DNA resolution. Virology 181, 716–720.
Hu, X., Carroll, L. J., Wolffe, E. J., and Moss, B. (1996). De novo synthesis 574–583.
Shuman, S. (1990). Catalytic activity of vaccinia mRNA capping enzymeof the early transcription factor 70-kilodalton subunit is required for
morphogenesis of vaccinia virions. J Virol. 70, 7669–7677. subunits coexpressed in Escherichia coli. J. Biol. Chem. 265, 11960–
11966.Joklik, W. K. (1962). Purification of four strains of poxvirus. Virology 18,
9 –18. Shuman, S., and Morham, S. G. (1990). Domain structure of vaccinia
virus mRNA capping enzyme. Activity of the Mr 95,000 subunit ex-Keck, J. G., Baldick, C. J., and Moss, B. (1990). Role of DNA replication
in vaccinia virus gene expression: A naked template is required for pressed in Escherichia coli. J. Biol. Chem. 265, 11967–11972.
Shuman, S., and Moss, B. (1990). Purification and use of vaccinia virustranscription of three late trans-activator genes. Cell 61, 801–809.
Luo, Y., Mao, X., Deng, L., Cong, P., and Shuman, S. (1995). The D1 messenger RNA capping enzyme. Methods Enzymol. 181, 170–180.
Shuman, S., Broyles, S. S., and Moss, B. (1987). Purification and charac-and D12 subunits are both essential for the transcription termination
factor activity of vaccinia virus capping enzyme. J Virol. 69, 3852– terization of a transcription termination factor from vaccinia virions.
J. Biol. Chem. 262, 12372–12380.3856.
AID VY 8820 / 6a53$$$402 10-29-97 11:02:57 viral AP: VY
409VACCINIA CAPPING ENZYME ts MUTANT
Stuart, D., Graham, K., Schreiber, M., Macaulay, C., and McFadden, G. Tutas, D. J., and Paoletti, E. (1977). Purification and characterization
of core-associated polynucleotide 5*-triphosphatase from vaccinia(1991). The target DNA sequence for resolution of poxvirus replicative
intermediates is an active late promoter. J. Virol. 65, 61–70. virus. J. Biol. Chem. 252, 3092–3098.
VanSlyke, J. K., Whitehead, S. S., Wilson, E. M., and Hruby, D. E. (1991).Stuart, D., Ellison, K., Graham, K., and McFadden, G. (1992). In vitro
resolution of poxvirus replicative intermediates into linear minichro- The multistep proteolytic maturation pathway utilized by vaccinia
virus P4a protein: A degenerate conserved cleavage motif withinmosomes with hairpin termini by a virally induced Holliday junction
endonuclease. J. Virol. 66, 1551–1563. core proteins. Virology 183, 467–478.
Venkatesan, S., Gershowitz, A., and Moss, B. (1980). Modification ofThompson, C. L., and Condit, R. C. (1986). Marker rescue mapping of
vaccinia virus temperature-sensitive mutants using overlapping cosmid the 5* end of mRNA: Association of RNA triphosphatase with the
RNA guanylyltransferase–RNA (guanine-7-)methyltransferase com-clones representing the entire virus genome. Virology 150, 10–20.
Towbin, H., Staehelin, T., and Gordon, J. (1979). Electrophoretic transfer plex from vaccinia virus. J. Biol. Chem. 255, 903–908.
Vos, J. C., Sasker, M., and Stunnenberg, H. G. (1991). Vaccinia virusof proteins from polyacrylamide gels to nitrocellulose sheets: Proce-
dure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350– capping enzyme is a transcription initiation factor. EMBO J. 10, 2553–
2558.4354.
Traktman, P. (1990). The enzymology of poxvirus DNA replication. Curr. Wertman, K. F., Drubin, D. G., and Botstein, D. (1992). Systematic muta-
tional analysis of the yeast ACT1 gene. Genetics 132, 337–350.Top. Microbiol. Immunol. 163, 93–124.
Turner, P., and Moyer, R. (1995). A PCR based method for manipulation Yu, L., and Shuman, S. (1996). Mutational analysis of the RNA triphos-
phatase component of vaccinia virus mRNA capping enzyme. J Virol.of the vaccinia virus genome that eliminates the need for cloning.
Biotechniques 13, 764–771. 70, 6162–6168.
AID VY 8820 / 6a53$$$402 10-29-97 11:02:57 viral AP: VY
